Skip to main content

Thoracic Brachytherapy

  • Chapter
  • First Online:
Book cover Brachytherapy

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1291 Accesses

Abstract

Brachytherapy for thoracic malignancies provides localized intrathoracic delivery of high-dose targeted radiotherapy, which can be very potent as a primary treatment, an adjuvant treatment, or a salvage treatment. We present our experience, data, and recommendations in this regard.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society (2015) Cancer facts & figures 2015. American Cancer Society, Atlanta

    Google Scholar 

  2. Brambilla E, Travis WD (2014) Lung cancer. In: Stewart BW, Wild CP (eds) World cancer report. World Health Organization, Lyon

    Google Scholar 

  3. Alberg AJ, Samet JM (2003) Epidemiology of lung cancer. Chest 123(1 Suppl):21S

    Article  PubMed  Google Scholar 

  4. Goldstraw P, Crowley J, Chansky K et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2(8):694

    Article  PubMed  Google Scholar 

  5. Arriagada R, Bergman B, Dunant A et al (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351

    Article  PubMed  Google Scholar 

  6. Pignon JP, Tribodet H, Scagliotti GV et al (2008) Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26:3552

    Article  PubMed  Google Scholar 

  7. Strauss GM, Herndon JE 2nd, Maddaus MA et al (2008) Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 26:5043

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yankauer S (1922) Two cases of lung tumour treated bronchoscopically. NY Med J 21:741–742

    Google Scholar 

  9. Kernan JD, Cracovaner AJ (1929) Carcinoma of the lung. Arch Surg 18:315–325

    Article  Google Scholar 

  10. Kernan JD (1933) Carcinoma of the lung and bronchus treatment with radon implantations and diathermy. Arch Otolaryngol 17(4):457–475

    Article  Google Scholar 

  11. Pool JL (1961) Bronchoscopy in the treatment of lung cancer. Trans Am Bronchoesoph Assoc 41:128–136

    CAS  Google Scholar 

  12. Graham EA, Singer JJ (1933) Successful removal of an entire lung for carcinoma of the bronchus. JAMA 18(101):1371–1374

    Article  Google Scholar 

  13. Henschke UK (1959) Interstitial implantation in the treatment of primary bronchogenic carcinoma. Am J Roentgenol Radium Ther Nucl Med 79:981–987

    Google Scholar 

  14. Hilaris B, Martini N (1988) The current state of intraoperative interstitial brachytherapy in lung cancer. Int J Radiat Oncol Biol Phys 15:1347–1354

    Article  CAS  PubMed  Google Scholar 

  15. Hilaris B, Liskow A, Bains M et al (1979) A new endobronchial implanter. Memorial Sloan Kettering Clin Bull 9(1):21–23

    CAS  Google Scholar 

  16. Mittal B, Matuschak C, Culpepper J (1984) Endobronchial interstitial brachytherapy using a bronchofiberscope with a flexible injector system. Radiology 152:219–220

    Article  CAS  PubMed  Google Scholar 

  17. Mittal B, Parsons J, Webster J et al (1986) Transbronchial radioactive implantation using a flexible injector system: an improved technique for endobronchial brachytherapy. Radiother Oncol 5:11–13

    Article  CAS  PubMed  Google Scholar 

  18. Mendiondo OA, Dillon M, Beach LJ (1983) Endobronchial brachytherapy in the treatment of recurrent bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 9(4):579–582

    Article  CAS  PubMed  Google Scholar 

  19. Seagren S, Harrell J, Horn R (1985) High dose rate intraluminal irradiation in recurrent endobronchial carcinoma. Chest 88:810–814

    Article  CAS  PubMed  Google Scholar 

  20. Speiser B, Spratling L (1990) Intermediate dose rate remote afterloading brachytherapy for intraluminal control of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 18(6):1443–1448

    Article  CAS  PubMed  Google Scholar 

  21. Gaspar L (1998) Brachytherapy in lung cancer. J Surg Oncol 67:60–70

    Article  CAS  PubMed  Google Scholar 

  22. Lo TCM, Girshovich L, Healey GA et al (1995) Low dose rate versus high dose rate intraluminal brachytherapy for malignant endobronchial tumors. Radiother Oncol 35(3):193–197

    Article  CAS  PubMed  Google Scholar 

  23. Lo TC, Beamis JF, Villanueva AG et al (2001) Intraluminal brachytherapy for malignant endobronchial tumors: an update on low-dose rate versus high-dose rate radiation therapy. Clin Lung Cancer 3(1):65–68

    Article  CAS  PubMed  Google Scholar 

  24. Marsiglia H, Baldeyrou P, Lartigau E et al (2000) High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys 47(3):665–672

    Article  CAS  PubMed  Google Scholar 

  25. Van Limbergen E, Pötter R (2002) Chapter 26. Bronchus cancer. In: GEC ESTRO handbook of brachytherapy, 1st edn. ESTRO, Leuven: ACCO; pp 545–560

    Google Scholar 

  26. Rivard M, Coursey BM, DeWerd LA et al (2004) Update of AAPM TG no. 43 report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys 31(3):633–674

    Article  PubMed  Google Scholar 

  27. Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E. The GEC ESTRO handbook of brachytherapy. Copyright 2002 by The Authors and ESTRO Printed by ACCO, Leuven

    Google Scholar 

  28. Joslin CAF, Flynn A, Hall EJ (2001) Principles and practice of brachytherapy using remote afterloading systems, 1st edn. Oxford University Press Inc, New York

    Google Scholar 

  29. Gollins SW, Burt PA, Barber PV et al (1994) High dose rate intraluminal radiotherapy for carcinoma of the bronchus: outcome of treatment of 406 patients. Radiother Oncol 33:31–40

    Article  CAS  PubMed  Google Scholar 

  30. Gollins SW, Burt PA, Barber PV et al (1996) Long-term survival and symptom palliation in small primary bronchial carcinomas following treatment with intraluminal radiotherapy alone. Clin Oncol (R Coll Radiol) 8(4):239–246

    Article  CAS  Google Scholar 

  31. Taulelle M, Chauvet B, Vincent P et al (1998) High dose rate endobronchial brachytherapy: results and complications in 189 patients. Eur Respir J 11:162–168

    Article  CAS  PubMed  Google Scholar 

  32. Hennequin C, Bleichner O, Tredaniel J et al (2007) Long-term results of endobronchial brachytherapy: a curative treatment? Int J Radiat Oncol Biol Phys 67(2):425–430

    Article  PubMed  Google Scholar 

  33. Aumount-Le Guilcher M, Prevost B et al (2011) High-dose-rate brachytherapy for non–small cell lung carcinoma: a retrospective study of 226 patients. Int J Radiat Oncol Biol Phys 79(4):1112–1116

    Article  Google Scholar 

  34. Nag S, Kelly JF, Horton JL et al (2001) Brachytherapy for carcinoma of the lung. Oncology (Williston Park) 15(3):371–381

    CAS  Google Scholar 

  35. Aygun C, Weiner S, Scariato A et al (1992) Treatment of non-small cell lung cancer with external beam radiotherapy and high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 23:127–132

    Article  CAS  PubMed  Google Scholar 

  36. Nori D, Allison R, Kaplan B et al (1993) High dose rate intraluminal irradiation in bronchogenic carcinoma* technique and results. Chest 104:1006–1011

    Article  CAS  PubMed  Google Scholar 

  37. Huber RM, Fischer R, Hautmann H et al (1997) Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors. Int J Radiat Oncol Biol Phys 38:533–540

    Article  CAS  PubMed  Google Scholar 

  38. Anacak Y, Mogulkoc N, Ozkok S et al (2001) High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer. Lung Cancer 34:253–259

    Article  CAS  PubMed  Google Scholar 

  39. Langendijk H, Jong J, Tjwa M et al (2001) External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol 58:257–268

    Article  CAS  PubMed  Google Scholar 

  40. Gejerman G, Mullokandov EA, Bagiella E et al (2002) Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension. Brachytherapy 1:204–210

    Article  PubMed  Google Scholar 

  41. Ozkok S, Karakoyun-Celik O, Goksel T et al (2008) High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients. Lung Cancer 62:326–333

    Article  PubMed  Google Scholar 

  42. Rochet N, Hauswald H, Stoiber EM et al (2013) Primary radiotherapy with endobronchial high-dose-rate brachytherapy boost for inoperable lung cancer: long-term results. Tumori 99(2):183–190

    CAS  PubMed  Google Scholar 

  43. Cotter GW, Herbert DE, Ellingwood KE et al (1991) Inoperable endobronchial obstructing lung carcinoma treated with combined endobronchial and external beam irradiation. South Med J 84(5):562–565

    CAS  PubMed  Google Scholar 

  44. Skowronek J, Piorunek T, Kanikowski M et al (2013) Definitive high-dose-rate endobronchial brachytherapy of bronchial stump for lung cancer after surgery. Brachytherapy 12(6):560–566

    Article  PubMed  Google Scholar 

  45. Quantrill SJ, Burt PA, Barber PV et al (2000) Treatment of endobronchial metastases with intraluminal radiotherapy. Respir Med 94:369–372

    Article  CAS  PubMed  Google Scholar 

  46. Burt PA, O’Driscoll BR, Notley HM et al (1990) Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron. Thorax 45:765–768

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Reveiz L, Rueda JR, Cardona AF. Palliative endobronchial brachytherapy for non-small cell lung cancer (Review). The Cochrane Library. 2012;(12):CD004284.

    Google Scholar 

  48. Delclos MR, Komaki R, Morice RC et al (1996) Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Radiology 201:279–282

    Article  CAS  PubMed  Google Scholar 

  49. Chang LL, Horvath J, Peyton W et al (1994) High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer. Int J Radiat Oncol Biol Phys 28(3):589–596

    Article  CAS  PubMed  Google Scholar 

  50. Chella A, Ambrogi MC, Ribechini A et al (2000) Combined Nd-YAG laser: HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study. Lung Cancer 27:169–175

    Article  CAS  PubMed  Google Scholar 

  51. Ung YC, Yu E, Falkson C et al (2006) The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review. Brachytherapy 5:189–202

    Article  PubMed  Google Scholar 

  52. Mallick I, Sharma SC, Behera D (2007) Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer- analysis of symptom response, endoscopic improvement and quality of life. Lung Cancer 55:313–318

    Article  PubMed  Google Scholar 

  53. Bedwinek J, Petty A, Bruton C et al (1991) The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 22:23–30

    Article  Google Scholar 

  54. Speiser BL, Spratling L (1993) Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys 25:579–587

    Article  CAS  PubMed  Google Scholar 

  55. Pisch J, Villamena PC, Harvey JC et al (1993) High dose-rate endobronchial irradiation in malignant airway obstruction. Chest 104:721–725

    Article  CAS  PubMed  Google Scholar 

  56. Kohek PH, Pakisch B, Glanzer H (1994) Intraluminal irradiation in the treatment of malignant airway obstruction. Eur J Surg Oncol 20:674–680

    CAS  PubMed  Google Scholar 

  57. Tredaniel J, Hennequin C, Zalcman G et al (1994) Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction. Chest 105:767–772

    Article  CAS  PubMed  Google Scholar 

  58. Ofiara L, Roman T, Schwartzman K et al (1997) Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma. Chest 112:946–953

    Article  CAS  PubMed  Google Scholar 

  59. Escobar-Sacristan JA, Granda-Orive JI, Jimenez GT et al (2004) Endobronchial brachytherapy in the treatment of malignant lung tumours. Eur Respir J 24:348–352

    Article  CAS  PubMed  Google Scholar 

  60. Kubaszewsk M, Skowronek J, Chichel A et al (2008) The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irradiated lung cancer. Neoplasma 55(3):239–245

    Google Scholar 

  61. Guarnaschelli JN, Jose BO (2010) Palliative high-dose–rate endobronchial brachytherapy for recurrent carcinoma: the University of Louisville experience. J Palliat Med 12(8):981–989

    Article  Google Scholar 

  62. Santos RS, Raftopoulos Y, Keenan RJ et al (2004) Bronchoscopic palliation of primary lung cancer. Surg Endosc 18:931–936

    Article  CAS  PubMed  Google Scholar 

  63. Miller JL, Phillips TW (1990) Neodymium:YAG laser and brachytherapy in the management of inoperable bronchogenic carcinoma. Ann Thorac Surg 50:190–196

    Article  PubMed  Google Scholar 

  64. Shea JM, Allen RP, Tharratt RS et al (1993) Survival of patients undergoing Nd:YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease. Chest 103:1028–1031

    Article  CAS  PubMed  Google Scholar 

  65. Freitag L, Ernst A, Thomas M et al (2004) Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax 59:790–793

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Weinberg BD, Allison RR, Sibata C et al (2010) Results of combined photodynamic therapy (PDT) and high dose rate brachytherapy (HDR) in treatment of obstructive endobronchial non-small cell lung cancer (NSCLC). Photodiagnosis Photodyn Ther 7:50–58

    Article  CAS  PubMed  Google Scholar 

  67. Gauwitz M, Ellerbroek N, Komaki R et al (1991) High dose endobronchial irradiation in recurrent bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 23:397–400

    Article  Google Scholar 

  68. Kelly JF, Delclos MR, Morice RC et al (2000) High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 48(3):697–702

    Article  CAS  PubMed  Google Scholar 

  69. Hennequin C, Tredaniel J, Chevret S et al (1998) Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis. Int J Radiat Biol Phys 42(1):21–27

    Article  CAS  Google Scholar 

  70. Allen AM, Abdelrahman N, Silvern D et al (2012) Endobronchial brachytherapy provides excellent long-term control of recurrent granulation tissue after tracheal stenosis. Brachytherapy 11(4):322–326, Epub 2012 Feb 28

    Article  PubMed  Google Scholar 

  71. Brenner B, Kramer MR, Katz A et al (2003) High dose rate brachytherapy for nonmalignant airway obstruction* New treatment option. Chest 124:1605–1610

    Article  PubMed  Google Scholar 

  72. Halkos ME, Godette KD, Lawrence C et al (2003) High dose rate brachytherapy in the management of lung transplant airway stenosis. Ann Thorac Surg 76:381–384

    Article  PubMed  Google Scholar 

  73. Kennedy AS, Sonnett JR, Orens JB et al (2000) High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: theoretical and clinical considerations. J Heart Lung Transplant 19:155–159

    Article  CAS  PubMed  Google Scholar 

  74. Kramer MR, Katz A, Yarmolovsky A et al (2001) Successful use of high dose rate brachytherapy for non-malignant bronchial obstruction. Thorax 56:415–416

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Madu CN, Machuzak MS, Sterman DH et al (2006) High-dose-rate (Hdr) brachytherapy for the treatment of benign obstructive endobronchial granulation tissue. Int J Radiat Oncol Biol Phys 66(5):1450–1456

    Article  PubMed  Google Scholar 

  76. Meyer A, Warszawski-Baumann A, Baumann R et al (2012) HDR brachytherapy: an option for preventing nonmalignant obstruction in patients after lung transplantation. Strahlenther Onkol 188:1085–1090

    Article  CAS  PubMed  Google Scholar 

  77. Rahman NA, Fruchter O, Shitrit D et al (2010) Flexible bronchoscopic management of benign tracheal stenosis: long term follow-up of 115 patients. J Cardiothorac Surg 5:2

    Article  PubMed  PubMed Central  Google Scholar 

  78. Serber W, Dzeda MF, Hoppe RT (1998) Radiation treatment of benign disease. In: Perez CA, Brady LW (eds) Principles and practice of radiation oncology. Lippincott-Raven Publishers, Philadelphia, pp 2170–2172

    Google Scholar 

  79. Tendulkar RD, Fleming PA, Reddy CA et al (2008) High-dose-rate endobronchial brachytherapy for recurrent airway obstruction from hyperplastic granulation tissue. Int J Radiat Oncol Biol Phys 70(3):701–706

    Article  PubMed  Google Scholar 

  80. Tscheikuna J, Disayabutr S, Kakanaporn C et al (2013) High dose rate endobronchial brachytherapy (HDR-EB) in recurrent benign complex tracheobronchial stenosis: experience in two cases. J Med Assoc Thai 96(Suppl 2):S252–S256

    PubMed  Google Scholar 

  81. Nag S, Abitbol AA, Anderson LL et al (1993) Consensus guidelines for high-dose-rate remote brachytherapy in cervical, endometrial, and endobronchial tumors. Int J Radiat Oncol Biol Phys 27:1241–1244

    Article  CAS  PubMed  Google Scholar 

  82. Hilaris BS (1994) Lung brachytherapy: an overview and current indications. Curr Perspect Thorac Oncol 4:45–53

    CAS  Google Scholar 

  83. Hilaris BS, Martini N (1979) Interstitial brachytherapy in cancer of the lung: a 20 year experience. Int J Radiat Oncol Biol Phys 5:1951–1956

    Article  CAS  PubMed  Google Scholar 

  84. Hilaris BS, Nori D, Martini N (1987) Intraoperative radiotherapy in stage I and II lung cancer. Semin Surg Oncol 3:22–32

    Article  CAS  PubMed  Google Scholar 

  85. Armstrong JG, Fass DE, Bains M et al (1991) Paraspinal tumors: techniques and results of brachytherapy. Int J Radiat Oncol Biol Phys 20:787–790

    Article  CAS  PubMed  Google Scholar 

  86. Fernando HC, Landreneau R, Mandrekar S et al (2014) Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small cell lung cancer. J Clin Oncol 32:2456–2462

    Article  PubMed  PubMed Central  Google Scholar 

  87. Landreneau RJ, Sugarbaker DJ, Mack MJ et al (1997) Wedge resection versus lobectomy for stage I (T1-T2 N0 M0) non-small cell lung cancer. J Thorac Cardiovasc Surg 113:691–700

    Article  CAS  PubMed  Google Scholar 

  88. Martini N, Bains MS, Burt ME et al (1995) Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109:120–129

    Article  CAS  PubMed  Google Scholar 

  89. Miller JI, Hatcher CR (1987) Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function. Ann Thorac Surg 44:340–343

    Article  CAS  PubMed  Google Scholar 

  90. Ginsberg RJ, Rubinstein LV (1995) Lobectomy versus limited resection for T1 N0 non-small cell cancer by the Lung Cancer Study Group. Ann Thorac Surg 60:615–623

    Article  CAS  PubMed  Google Scholar 

  91. Chen A, Galloway M, Landreneau R et al (1999) Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 44(5):1057–1063

    Article  CAS  PubMed  Google Scholar 

  92. D’Amato TA, Galloway M, Szydlowski G et al (1998) Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. Chest 114(4):1112–1115

    Article  PubMed  Google Scholar 

  93. Lee W, Daly BD, DiPetrillo TA et al (2003) Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg 75:237–242

    Article  PubMed  Google Scholar 

  94. Colonias A, Betler J, Trombetta M et al (2011) Mature follow-up for high-risk stage I non-small cell lung carcinoma treated with sublobar resection and intraoperative 125-I brachytherapy. Int J Radiat Oncol Biol Phys 79(1):105–109

    Article  PubMed  Google Scholar 

  95. McKenna RJ, Mahtabifard A, McKenna R et al (2008) Wedge resection and brachytherapy for lung cancer in patients with poor pulmonary function. Ann Thorac Surg 85(2):S733–S736

    Article  PubMed  Google Scholar 

  96. Parashar B, Port J, Arora S et al (2015) Analysis of stereotactic radiation vs. wedge resection vs. wedge resection plus Cesium-131 brachytherapy in early stage lung cancer. Brachytherapy 2015. pii: S1538-4721(15)00455-9. doi:10.1016/j.brachy.2015.04.001

    Google Scholar 

  97. Fernando HC, Landreneau R, Mandrekar S et al (2011) The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial. J Thorac Cardiovasc Surg 142(3):554–562

    Article  PubMed  PubMed Central  Google Scholar 

  98. Fernando HC, Landreneau R, Mandrekar S et al (2015) Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: Results from ACOSOG Z4032 (Alliance) multicenter randomized trial. J Thorac Cardiovasc Surg 149:718–726

    Article  PubMed  PubMed Central  Google Scholar 

  99. Mutyala S, Stewart A, Khan A et al (2010) Permanent Iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. Int J Radiat Oncol Biol Phys 76(4):1114–1120

    Article  PubMed  Google Scholar 

  100. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69

    Article  PubMed  Google Scholar 

  101. Baquet CR, Commiskey P, Mack K et al (2005) Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 97:1471

    PubMed  PubMed Central  Google Scholar 

  102. Edge SB, Byrd DR, Compton CC et al (eds) (2010) American Joint Committee on cancer staging manual, 7th edn. Springer, New York

    Google Scholar 

  103. Tepper J, Krasna MJ, Niedzwiecki D et al (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086

    Article  CAS  PubMed  Google Scholar 

  104. Van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084

    Article  PubMed  Google Scholar 

  105. Walsh TN, Noonan N, Hollywood D et al (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462

    Article  CAS  PubMed  Google Scholar 

  106. Harvey JC, Fleischman EH, Bellotti JE et al (1993) Intracavitary radiation in the treatment of advanced esophageal carcinoma: a comparison of high dose rate vs. low dose rate brachytherapy. J Surg Oncol 52:101–104

    Article  CAS  PubMed  Google Scholar 

  107. Tamaki T, Ishikawa H, Takahashi T et al (2012) Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer. Brachytherapy 11:130–136

    Article  PubMed  Google Scholar 

  108. Liu H, Wang Q, Wan X et al (2014) Californium-252 neutron brachytherapy combined with external beam radiotherapy for esophageal cancer: long-term treatment results. Brachytherapy 13:514–521

    Article  PubMed  Google Scholar 

  109. Gaspar LE, Nag S, Herskovic A et al (1997) American brachytherapy society consensus guidelines for brachytherapy of esophageal cancer. Int J Radiat Oncol Biol Phys 38(1):127–132

    Article  CAS  PubMed  Google Scholar 

  110. Hareyama M, Nishio M, Kagami Y et al (1992) Intracavitary brachytherapy combined with external beam irradiation for squamous cell carcinoma of the thoracic esophagus. Int J Radiat Oncol Biol Phys 24:235–240

    Article  CAS  PubMed  Google Scholar 

  111. Hishikawa Y, Kurisu K, Taniguchi M et al (1991) High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years’ experience in Hyogo College of Medicine. Radiother Oncol 21:107–114

    Article  CAS  PubMed  Google Scholar 

  112. Gaspar LE, Kocha WI, Barnett R et al (1993) Cancer of the esophagus: brachytherapy, external beam radiation and chemotherapy. Cancer J 6:196–200

    Google Scholar 

  113. Gaspar LE, Winter K, Kocha WI et al (2000) A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy for patients with localized carcinoma of the esophagus (RTOG 9207): final report. Cancer 88(5):988–995

    Article  CAS  PubMed  Google Scholar 

  114. Sharma V, Agarwal J, Dinshaw K et al (2000) Late esophageal toxicity using a combination of external beam radiation, intraluminal brachytherapy and 5-fluorouracil infusion in carcinoma of the esophagus. Dis Esophagus 13:219–225

    Article  CAS  PubMed  Google Scholar 

  115. Yorozu A, Dotiya T, Oki Y (1999) High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 45:271–275

    Article  CAS  PubMed  Google Scholar 

  116. Fabrini MG, Perrone F, DeLiguoro M et al (2010) A single-institutional brachytherapy experience in the management of esophageal cancer. Brachytherapy 9(2):185–191

    Article  PubMed  Google Scholar 

  117. Lin J (2013) T1 esophageal cancer; request an endoscopic mucosal resection (EMR) for in-depth review. J Thorac Dis 5(3):353–356

    PubMed  PubMed Central  Google Scholar 

  118. Manner H, May A, Pech O et al (2008) Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 103:2589–2597

    Article  PubMed  Google Scholar 

  119. Manner H, Pech O, Heldmann Y et al (2013) Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 11:630–635

    Article  PubMed  Google Scholar 

  120. Ishikawa H, Nonaka T, Sakurai H et al (2010) Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results. Int J Radiat Oncol Biol Phys 76(2):452–459

    Article  PubMed  Google Scholar 

  121. Pasquier D, Mirabel X, Adenis A et al (2006) External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Int J Radiat Oncol Biol Phys 65(5):1456–1461

    Article  PubMed  Google Scholar 

  122. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology Group. JAMA 281(17):1623–1627

    Article  CAS  PubMed  Google Scholar 

  123. Sur RK, Singh DP, Sharma SC et al (1992) Radiation therapy of esophageal cancer: role of high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 22:1043–1046

    Article  CAS  PubMed  Google Scholar 

  124. Yin WB (1990) Brachytherapy of carcinoma of the esophagus in China, 1970–1974 and 1982–1984. In: Martinez AA, Orton CG, Moulds RF (eds) Brachytherapy: HDR and LDR. Nucletron Corp, Columbia, pp 52–56

    Google Scholar 

  125. Kumar S, Dimri K, Khurana R et al (2007) A randomized trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Radiother Oncol 83:139–147

    Article  CAS  PubMed  Google Scholar 

  126. Muijs CT, Beukema JC, Mul VE et al (2012) External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma. Radiother Oncol 102:303–308

    Article  PubMed  Google Scholar 

  127. Vuong T, Szego P, David M et al (2005) The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy. Int J Radiat Oncol Biol Phys 63(3):758–764

    Article  PubMed  Google Scholar 

  128. Amdal CD, Jacobsen AB, Sandstad B et al (2013) Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomized phase III trial. Radiother Oncol 107(3):428–433

    Article  PubMed  Google Scholar 

  129. Grazziotin Reisner R, Reisner ML, Ferreira MA et al (2015) Measuring relief of dysphagia in locally advanced esophageal carcinoma patients submitted to high-dose-rate brachytherapy. Brachytherapy 14(1):84–90

    Article  PubMed  Google Scholar 

  130. Rupinski M, Zagorowicz E, Regula J et al (2011) Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a)(Revides II). Am J Gastroenterol 106(9):1612–1620

    Article  CAS  PubMed  Google Scholar 

  131. Skowronek J, Piotrowski T, Zwierzchowski G (2004) Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer. Brachytherapy 3(2):87–94

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Athanasios Colonias MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Renz, P., Van Deusen, M., Landreneau, R.J., Colonias, A. (2016). Thoracic Brachytherapy. In: Montemaggi, P., Trombetta, M., Brady, L. (eds) Brachytherapy. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/978-3-319-26791-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26791-3_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26789-0

  • Online ISBN: 978-3-319-26791-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics